Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

XLO - Xilio Therapeutics, Inc.

IEX Last Trade
1.05
0   0%

Share volume: 100
Last Updated: Fri 10 Jan 2025 06:05:07 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): -0.49%

PREVIOUS CLOSE
CHG
CHG%
$1.05
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2024-03-31 2024-06-30 2024-09-30
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024
Report Date 2024-05-14 2024-08-08 2024-11-07
Total revenue 0.000 2.357 M 2.263 M
Cost of revenue 0.000 0.000 0.000
Gross profit 0.000 2.357 M 2.263 M
    inf% -3.99%  
Operating expenses 16.539 M 17.031 M 17.066 M
Selling general and admin 6.139 M 5.815 M 6.307 M
Research and development 10.400 M 11.216 M 10.759 M
Total expenses 17.487 M 17.061 M 17.025 M
    -2.44% -0.21%  
Operating income -17.487 M -14.704 M -14.762 M
Ebit -17.203 M -13.925 M -14.020 M
Pretax income -17.203 M -13.925 M -14.020 M
    -19.05% 0.68%  
Income tax 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000
         
Net income -17.203 M -13.925 M -14.020 M
    19.05% -0.68%